Furthermore, SUCLG2 expression was significantly elevated in various cancer tissues, including those of GBM, breast cancer, cholangiocarcinoma, bladder cancer, and lung cancer (Fig. S1B). This evidence concerns the gene SUCLG2 and urinary bladder carcinoma.